Complete Surgical Cytoreduction of Advanced Ovarian Carcinoma Using the Argon Beam Coagulator
- 1 October 2001
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 83 (1), 39-48
- https://doi.org/10.1006/gyno.2001.6344
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinomaCancer, 2000
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- Review of ovarian cancer at the University of Texas Systems Cancer Center, M. D. Anderson Hospital and Tumor InstituteAmerican Journal of Obstetrics and Gynecology, 1979
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968